Buchumschlag

Upregulation of PD-L1 and PD-L2 in neck node metastases of head and neck squamous cell carcinoma

Background This study aimed on evaluating the expression levels of the immune checkpoint proteins, PD-L1 and PD-L2, in tissue specimens of 175 oral squamous cell carcinomas (OSCC) and 33 corresponding lymph node metastases (LNM). Methods Tissue microarrays of primary OSCC and matched LNM were invest...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Moratin, Julius (VerfasserIn) , Safaltin, Ayse (VerfasserIn) , Herpel, Esther (VerfasserIn) , Hoffmann, Jürgen (VerfasserIn) , Freier, Kolja (VerfasserIn) , Heß, Jochen (VerfasserIn) , Horn, Dominik (VerfasserIn)
Weitere Verfasser: Semmelmayer, Karl (BerichterstatterIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 01 March 2019
In: Head & neck
Year: 2019, Jahrgang: 41, Heft: 8, Pages: 2484-2491
ISSN:1043-3074
DOI:10.1002/hed.25713
Online-Zugang:Verlag, Volltext: https://doi.org/10.1002/hed.25713
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/hed.25713
Volltext
Verfasserangaben:Julius Moratin MD, DMD, Karl Metzger DMD, Ayse Safaltin DMD, Esther Herpel MD, Jürgen Hoffmann MD, DMD, Kolja Freier MD, DMD, Jochen Hess PhD, Dominik Horn MD, DMD
Beschreibung
Zusammenfassung:Background This study aimed on evaluating the expression levels of the immune checkpoint proteins, PD-L1 and PD-L2, in tissue specimens of 175 oral squamous cell carcinomas (OSCC) and 33 corresponding lymph node metastases (LNM). Methods Tissue microarrays of primary OSCC and matched LNM were investigated via immunohistochemistry regarding PD-L1/PD-L2 expression. Results were compared for primary tumors and corresponding metastases and correlated with clinicopathological data. Results PD-L1 expression in cancer cells correlated significantly with tumor size, and the presence of regional metastases (P < 0.01). PD-L1 expression was significantly higher in metastases as compared to primary OSCC (P < 0.05). Overall survival was significantly worse in patients with higher levels of PD-L1 and PD-L2 score (P < 0.05). Conclusions This is the first publication to compare PD-L1 and PD-L2 expression in primary OSCC and matched LNM. The results indicate that anti-PD-1 therapy may be of therapeutic use even in early stage OSCC to prevent further progression.
Beschreibung:Gesehen am 17.01.2020
Beschreibung:Online Resource
ISSN:1043-3074
DOI:10.1002/hed.25713

Ähnliche Einträge